Cleara Biotech
Netherlands · Founded 2018 · $50.5M raised
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- clearabiotech.com
- Total Funding
- $50.5M
- Last Round
- $45.0M Venture RoundJan 2025
- Rounds
- 3
About
Cleara Biotech develops senolytic therapies targeting FOXO4-p53 cellular senescence pathways for cancer treatment and aging-related diseases.
Summary
Cleara Biotech is a Biotech company based in Netherlands, founded in 2018. It has raised $50.5M in total across 3 rounds, most recently a $45.0M Venture Round round in Jan 2025.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...